Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

APPOINTMENTS: Array, Bioniz, Galmed, Marathon Pharma, Selecta and Valeant

Executive Summary

Former Allergan PLC CEO Dr. David Pyott has joined the board of and invested in emerging biotech Bioniz Therapeutics, while Valeant Pharmaceuticals International Inc. and Selecta Biosciences Inc. have also allotted new board members. Marathon Pharmaceuticals LLC, Array BioPharma Inc. and Galmed Pharmaceuticals Ltd. have made a series of executive appointments.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097056

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel